Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
ACS Pharmacol Transl Sci ; 2(3): 213-216, 2019 Jun 14.
Artigo em Inglês | MEDLINE | ID: mdl-32259057

RESUMO

Translational science is defined as the field of investigation focused on understanding the scientific and operational principles underlying each step of the translational process. Further development of the field is advanced by describing the key desirable characteristics of individuals who seek to uncover these principles to increase the efficiency and efficacy of translation. The members of Translation Together, a newly launched international collaborative effort to advance translational innovation, present here a consensus representation of the fundamental characteristics of a translational scientist. We invite all stakeholders to contribute in the ongoing efforts to develop the field and educate the next generation of translational scientists.

3.
Cancer Chemother Pharmacol ; 64(3): 473-83, 2009 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-19104812

RESUMO

BACKGROUND: Miriplatin (formerly SM-11355), a novel lipophilic platinum complex developed to treat hepatocellular carcinoma, is administered into the hepatic artery using an oily lymphographic agent (Lipiodol Ultra-Fluide) as a carrier. We clarified the usefulness of miriplatin as an agent for transarterial chemoembolization. METHODS: Platinum compounds released from miriplatin into serum, medium and Earle's balanced salt solution were examined. Then, miriplatin and cisplatin were administered to rats bearing hepatoma AH109A tumors in livers. Platinum concentrations in tissues and DNA were assessed. RESULTS: Miriplatin showed a more sustained release than cisplatin. Dichloro[(1R, 2R)-1, 2-cyclohexane diamine-N, N']platinum, the most abundant platinum compound released from miriplatin, was as effective as cisplatin in inhibiting the growth of cells. Miriplatin was selectively disposed of in tumors, maintained in tumors longer than cisplatin and caused apparent tumor regression inducing platinum-DNA adducts to form and massive apoptosis. CONCLUSION: Miriplatin appears to be a suitable chemotherapeutic agent for transarterial chemoembolization.


Assuntos
Antineoplásicos/farmacologia , Quimioembolização Terapêutica/métodos , Óleo Iodado/administração & dosagem , Neoplasias Hepáticas Experimentais/tratamento farmacológico , Compostos Organoplatínicos/farmacologia , Animais , Antineoplásicos/administração & dosagem , Antineoplásicos/farmacocinética , Cisplatino/farmacologia , Adutos de DNA/metabolismo , Preparações de Ação Retardada , Portadores de Fármacos/administração & dosagem , Ensaios de Seleção de Medicamentos Antitumorais , Artéria Hepática , Infusões Intra-Arteriais , Neoplasias Hepáticas Experimentais/patologia , Linfografia , Masculino , Transplante de Neoplasias , Compostos Organoplatínicos/administração & dosagem , Compostos Organoplatínicos/farmacocinética , Ratos
4.
Gene Expr ; 11(2): 77-83, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12837038

RESUMO

To determine the effect on gene expression of trace levels of reactive oxygen species from mitochondria, we used the mRNA differential display technique to compare gene expression in two cell lines: M15, which overexpresses mitochondrial phospholipid hydroperoxide glutathione peroxidase (mtPHGPx), in rat basophilic leukemia RBL-2H3 cells, and a control cell line, S1. We isolated 27 differentially expressed genes, including 10 previously unreported sequences. These genes included cytoskeletal proteins (beta-tubulin, nonmuscle myosin alkali light chain, and vimentin), growth or proliferation regulators [growth differentiation factor 1 (Gdf-1), Rap1a, and inhibitor of growth 3 (Ing3)], and others. Although the expression of most of the isolated genes did not respond to ROS (hydrogen peroxide) or antioxidant (pyrolidine dithiocarbamate) treatment, the expression of Gdf-1 was downregulated by hydrogen peroxide treatment. Thus, low levels of ROS produced in mitochondria during normal cellular metabolism can modulate gene expression.


Assuntos
Proteínas do Citoesqueleto/genética , Expressão Gênica/efeitos dos fármacos , Glutationa Peroxidase/metabolismo , Peróxido de Hidrogênio/farmacologia , Peptídeos e Proteínas de Sinalização Intercelular/genética , Mitocôndrias/enzimologia , Proteínas do Tecido Nervoso/genética , Animais , Antioxidantes/farmacologia , Regulação para Baixo , Perfilação da Expressão Gênica , Fator 1 de Diferenciação de Crescimento , Fosfolipídeo Hidroperóxido Glutationa Peroxidase , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Ratos , Espécies Reativas de Oxigênio , Tiocarbamatos/farmacologia , Células Tumorais Cultivadas , Regulação para Cima
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...